Dallas surgeon helps Ukrainian soldiers injured in battle

Dr. Jorge Corona returns from Ukraine, where he used MedCAD’s custom-designed, 3D-printed facial implants to help reconstruct the faces of soldiers injured in battle.

DALLAS TEXAS, December 5th, 2024 (FOX News) —

Dr. Jorge Corona, a Dallas-based surgeon, is part of a medical mission helping Ukrainian soldiers injured in the war with Russia. Using 3D-printed surgical implants donated by MedCAD, Corona reconstructs the faces of disfigured soldiers, restoring a sense of humanity to those who have suffered devastating injuries. Sponsored by Leap Global Missions, his recent work in Kyiv included operating on a soldier who lost both eyes and collaborating with other medical professionals on cases such as a U.S. volunteer fighter nicknamed “Gandalf,” who had his jaw reconstructed with MedCAD implants. Back in Dallas, Corona toured MedCAD’s Plano facility to witness the innovative 3D printing process that enables such life-changing surgeries. Grateful to provide hope and healing, Corona views this humanitarian work as his contribution to the Ukrainian cause.

Certain information set forth in this presentation contains “forward-looking information”, including “future-oriented financial information” and “financial outlook”, under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, the information contained herein constitutes forward-looking statements and includes, but is not limited to, the (i) projected financial performance of the Company; (ii) completion of, and the use of proceeds from, the sale of the shares being offered hereunder; (iii) the expected development of the Company’s business, projects, and joint ventures; (iv) execution of the Company’s vision and growth strategy, including with respect to future M&A activity and global growth; (v) sources and availability of third-party financing for the Company’s projects; (vi) completion of the Company’s projects that are currently underway, in development or otherwise under consideration; (vi) renewal of the Company’s current customer, supplier and other material agreements; and (vii) future liquidity, working capital, and capital requirements. Forward-looking statements are provided to allow potential investors the opportunity to understand management’s beliefs and opinions in respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment.

These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements.

Although forward-looking statements contained in this presentation are based upon what management of the Company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances or management’s estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.